A carregar...
Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
Neoadjuvant chemotherapy is the current standard of care for large, advanced, and/or inoperable tumors, including triple‐negative breast cancer. Although the clinical benefits of neoadjuvant chemotherapy have been illustrated through numerous clinical trials, more than half of the patients do not ex...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7476842/ https://ncbi.nlm.nih.gov/pubmed/32692484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3284 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|